D72.110

Clinical Causes: The precise cause of IHES is unknown, which is why it is classified as idiopathic. Potential genetic factors may contribute, though no specific mutations have been definitively linked. Dysregulation of immune system processes leading to uncontrolled eosinophil proliferation. Secondary causes such as parasitic infections or other underlying diseases should be ruled out before diagnosing IHES.

Key Symptoms: Fatigue and general malaise Unintended weight loss Fever and night sweats Skin rashes or lesions Swelling or pain in the abdomen due to organ involvement Shortness of breath or cough if lungs are affected Chest pain or irregular heartbeats if the heart is involved Neurological symptoms if the nervous system is compromised Enlargement of lymph nodes or spleen

Diagnosis Path: Complete blood count (CBC) with differential to identify elevated eosinophil levels Bone marrow biopsy to examine marrow cellularity and eosinophil proliferation Imaging studies such as ultrasound, CT, or MRI to evaluate organ involvement Exclusion of other causes of eosinophilia, including parasitic infections, allergic reactions, and specific diseases Serological tests and molecular studies to rule out secondary or hereditary eosinophilia Assessment of affected organs to determine the extent of damage

Treatment Protocols: Corticosteroids like prednisone to suppress eosinophil production and inflammation Cytotoxic agents such as hydroxyurea or interferon-alpha for cases resistant to steroids Targeted therapies including monoclonal antibodies like mepolizumab that inhibit eosinophil activity Managing organ-specific complications with appropriate interventions Regular monitoring through blood tests and imaging to assess response to therapy Addressing any secondary causes if identified during the diagnostic process